NMPA Approval

Hemofiltration Replacement Fluid of Sodium Citrate

Approval Number

国药准字H20253505

Company成都青山利康药业股份有限公司

Registration Date

March 4, 2025

Drug Information

Generic Name

枸橼酸钠血滤置换液

Dosage Form

注射剂

Strength

5000ml

Drug Type

化学药品

Registration Date

March 4, 2025

Company Information

Applicant Company

Company Name成都青山利康药业股份有限公司

Company Address

成都高新区高朋大道14号

Manufacturing Company

Company Name成都青山利康药业股份有限公司

Company Address

成都市双流区西航港空港五路2888号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

枸橼酸钠血滤置换液 - NMPA 批准文号 | MedPath